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Abstract 
Background: To evaluate the immunization status, 
complications and clinical outcome in children 
admitted with measles. 
Methods : In this descriptive study 150 patients( 8 
months to 12 years of age), with clinical diagnosis of 
Measles i.e. high grade fever, maculopapular rash, 
coryza, cough and conjunctivitis with its 
complications were included. Relevant information 
regarding age, sex immunization status and clinical 
presentation were also recorded. Immunization 
status of the patients was checked by examining the 
EPI card where available or parental enquiry if EPI 
card was not available. All the relevant 
investigations like CBC, serum electrolytes, X ray 
chest were carried out besides history and clinical 
examination. CSF examination was done where 
needed.  All the patients were observed for 
complications like encephalitis, pneumonia, 
diarrhea, otitis media and corneal  ulcers. They were 
managed according to the standard protocol of the 
hospital.  
Results: Of the 150 paediatric patients with 
diagnosis of measles included in the study, eighty 
nine(59.33%) were males. Mean age of the patients 
was 25 months. Seventy eight (52%) patients were 
well-nourished and 72(48%) were undernourished. 
Out of 150 patients 62% had received measles 
vaccine. Among vaccinated patients 5.33% patients 
had received two doses of measles vaccine and 85 
had one dose. Majority (88%) developed 
complications. Pneumonia (43.33%) followed by 
diarrhea (23.33%) were the  commonest. Six patients 
(4%) expired.   
Conclusion:There is a need to improve the 
nutritional status of the children and good coverage 
for the measles vaccine. The EPI needs to be 
strengthened. 
Key  Words: Measles, Complications, Encephalitis, 
Pneumonia. 
 
Introduction 
      Measles is one of the most contagious viral disease 
caused by a RNA virus with only one antigenic type.1 
It is more common in preschool age and spreads 
through respiratory tract by droplet infection, mostly 
during the prodromal period. The incubation period of 
measles is 9-12 days. The period of infectivity is 3-4 
days prior to appearance and 4-6 days after the 
disappearance of rash. Despite a vaccine preventable 
disease, it still poses a major public health problem in 
many developing countries. Measles is endemic 
throughout the world and epidemics occur in spring 
and winter season.2  
     In developing countries, measles is a major cause of 
childhood morbidity and mortality due to underlying 
malnutrition and overcrowding.3 According to the 
World Health Organization (WHO), measles is a 
leading cause of childhood mortality with 139,000 
measles deaths globally in 2010, and 95% of all 
measles related deaths occur in low income countries 
with poor health infrastructure.4 Pakistan has been hit 
by measles epidemic that has claimed the lives of 
hundreds of children. In 2012, there was 15,000 cases 
and 305 deaths.4 The World Health organization has 
recorded nearly 40,000 cases   and 700 deaths in 2013.  
    The classical signs and symptoms of measles include 
4-5 days fever, the three Cs .i.e. cough, coryza, 
conjunctivitis and rash. The classical measles rash is 
generalized maculopapular, erythematous rash 
starting from back of ear followed by spread to head, 
neck and then covers the whole body. The rash   
changes its colour from red to dark brown before 
disappearing. It is endemic throughout the world but 
has epidemic spread in spring season.5 Complications 
with measles are relatively common, ranging from 
mild to life threatening. These complications are 
diarrhoea, pneumonia, otitis media, encephalitis, 
corneal ulceration and myocarditis. Measles can lead 
to lifelong disabilities including blindness, brain 
damage and deafness.6 
     Frequent measles outbreaks are seen in those 
countries that offer only one dose of vaccine through 
Expanded Programme on Immunization (EPI). 
However countries where two doses of measles 
vaccine are given, have experienced a decrease in the 
number of cases and decrease in the number of deaths, 
presumably because of the development of herd 
immunity.7 The Strategic Advisory Group of Experts 
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on Immunization has recommended that all children 
should receive 2 doses of measles vaccine.8 The 
effectiveness of measles vaccination is based on 
several host and vaccine factors. The most important 
factors are age at vaccination and receipt of a 2nd 
dose.9 In few countries two dose regime vaccine has 
eliminated measles in their areas. One example is 
Finland, they have eliminated measles, mumps and 
rubella over a 12-year period using a two-dose 
measles, mumps and rubella vaccine (MMR) schedule 
given between 14 and 16 months and at age six years.10 
WHO and the UNICEF have included Pakistan one of 
the 47 priority countries for accelerated sustainable 
measles mortality reduction activities as it contributes 
to a large proportion of measles deaths worldwide.11 
World Health Organization has planned to reduce 
measles deaths by 90% by 2015 and to eliminate 
measles in five out of six regions before 2020.11 
     According to WHO, measles immunization 
coverage in Pakistan was 59% in 2002 and has 
increased to 80% in 2009.12 Although measles is a 
preventable disease but it still remains a major killer 
and causes over 1 million deaths worldwide each 
year.13 Mortality has decreased dramatically since the 
introduction of two doses of live attenuated vaccine. 
Prevention of measles using vaccination is still the 
most important strategy in countries where adequate 
infrastructure for health is not available.14 Keeping in 
view the recent measles epidemics in Pakistan and its 
associated complications and sequelae, its 
aggressiveness and contagiousness, the present study 
was undertaken to evaluate the immunization status, 
complications and outcome of measles in children 
admitted in our tertiary care hospital. 
 
Patients and Methods 
    This descriptive study was carried out at 
Department of Paediatrics, Railway Hospital 
Rawalpindi from 1st January 2013 to 31st December 
2013. Patients with clinical diagnosis of Measles i.e. 
high grade fever, maculo-papular rash, coryza, cough 
and conjunctivitis with its complications from 8 
months to 12 years of age were included in the study. 
Patients below 8 months of age were excluded from 
the study as they were considered to be protected from 
measles by the maternal antibodies. Informed consent 
was taken from the parents. Immunization status of 
the patients were checked by examining the EPI card 
where available or parental enquiry if EPI card was 
not available. All the relevant investigations like CBC, 
serum electrolytes and X ray chest were carried out. 
CSF examination was done where needed. All patients 
were given Vitamin A supplementation. All the 
patients were observed for complications.  Those 
patients who were critically ill and were not 
maintaining oxygen saturation were managed with 
mechanical ventilation. Malnutrition was classified as 
mild, moderate and severe according to the WHO 
classification.  
Results 
    A total of 150 paediatric patients with diagnosis of 
measles were included in the study, out of which 
59.33% were males and 40.67% were females. Majority 
of the patients were in the age group of >8 to 12  
months(35.3 %) and 13 -24 months ( 28 %) (Table 1)..  
 
Table 1 : Age distribution among patients (n = 150) 
Age in months No. of Patients 
> 12 53 
13 – 24 42 
25 – 36 22 
37 – 48 11 
49 – 60 11 
61 – 72 6 
73 – 84 3 
85 – 96 2 
 
Table 2: Measles – Nourishment status 
Nourishment status No(%) 
Well- nourished 78(52) 
Under-nourished 72(48) 
 
Table 3: Vaccination Status 
Vaccination status No(%) 
Vaccinated 93(62) 
Not vaccinated 57(38) 
 
Table 4: Number of vaccine doses received by 
vaccinated (n=93) 
Doses of vaccine received No(%) 
Double  dose  8(5.33) 
Single dose 85(94.7) 
 
Table 5: Measles – Complications (n=132) 
Complications No(%) 
Pneumonia 65(43.33) 
Diarrhoea 35(23.33) 
Encephalitis 10(6.67) 
Corneal ulcers 9(6) 
Flaring of Tuberculosis 10(6.67) 
Thrombocytopenia 1(0.75) 
Otitis media 1(0.75) 
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      Mean age of the patients was 25 months. Seventy 
eight (52%) patients were well-nourished and 72(48%) 
were undernourished In under-nourished patients 31 
(20.67%) were 1st degree malnourished, 22 (14.67%) 
were 2nd degree, and 19 (12.67%) were 3rd degree 
malnourished (Table 2). Out of 150 patients 62% 
patients had received measles vaccine and 38% were 
unvaccinated. Among 93 vaccinated patients only 
8(5.33%) patients had received two doses of measles 
vaccine and 85(94.7%) had one dose(Table 3 &4). 
Among 150 patients 132(88%) patients developed 
complications. Pneumonia (43.33%) was the  
commonest complication,followed by diarrhea 
(23.33%)(Table 5).   
 
Discussion 
    Measles is a highly contagious disease. Although a 
safe and cost effective vaccine is available but it is still 
a major health problem worldwide.  Measles 
epidemics continue to occur over the last decade in 
many regions of the world including Pakistan causing 
significant morbidity and mortality. Lack of proper 
health infrastructure, low vaccination coverage, less 
than two doses of vaccine, vaccine failure and poor 
nutrition are the main factors responsible in the 
resurgence of measles.15 
    There is no specific antiviral treatment for measles 
and vaccination remains the most effective way to 
prevent measles infection. Live attenuated measles 
virus vaccine should be given at 9 months and then at 
12 months. Measles vaccine is also incorporated with 
mumps and rubella vaccine as a combined vaccine 
(MMR). The current ACIP recommendations for 
routine vaccination for children indicate a first dose of 
MMR at 12-15 months of age with a second dose at 
school entry (4-6 years).16 Pakistan stands as a high 
susceptibility country for measles outbreaks. A 
reduction in measles outbreaks cannot be expected in a 
partially vaccinated population of infants and 
children. The priority would be to increase 
immunization coverage, reduce regional variations in 
coverage levels and strengthen surveillance with 
vaccination/re-vaccination of exposed children in 
areas of measles outbreaks.17 
     When a patient is suspected of having measles, a 
case investigation should be started immediately. 
Timely and thorough case investigation should: 
confirm the patient’s diagnosis; ensure appropriate 
medical follow-up for affected persons; identify the 
source of infection; locate persons who may have been 
exposed; and isolate potentially infectious persons to 
prevent transmission of illness in the community.16 A 
person can be considered exposed to measles if they 
shared the same airspace as a measles case during the 
case’s infectious period. A susceptible individual can 
be considered who has not received 2 doses of measles 
containing vaccine on or after his/her 1st birthday.16 
     In present  study a significant proportion of measles 
cases developed complications and were admitted in 
hospital. Majority of patients were over 1 year of age. 
Mean age of the patients was 25 months. Similar 
results have been reported by Imran Q et al where 
mean age was 23 months. 17 Studies from West Bengal, 
India and Thailand have shown similar results.18,19 In 
the present study measles was more common in male 
patients as compared with females.   Previously some 
studies had shown male predominance while others 
have shown female predominance. This may be due to 
the fact that our society is male dominant society and 
male patients are brought to medical attention earlier 
than female patients.20 
    Studies revealed that  malnourished children 
experience more severe measles infection at greater 
frequency due to their altered immune response.15,21,22 
Pneumonia occurs more in the malnourished children. 
The reason for increased prevalence of pneumonia in 
malnourished children with measles is due to the fact 
that Measles virus causes transient but profound 
immunosuppression  resulting in increased 
susceptibility to secondary bacterial and viral 
infections.17,18,23 
    The outcome in measles patients is poor even in 
developed countries especially when it is associated 
with complications like encephalitis, severe 
pneumonia or diarrhea with severe de-hydration 24. 
The mortality in our study is 6 (4%) which is almost 
similar to other studies done in Pakistan and 
India.15,18,24-26 Pakistan stands as a high susceptibility 
country for measles outbreaks because of low level 
vaccine coverage (54%), Epidemic out breaks are 
expected in a partially vaccinated population of 
infants and children. The priority would be to increase 
immunization coverage, improving nutritional status 
and improvement in health infrastructure. 
 
Conclusion 
1. Patients of measles can develop severe 
complications like pneumonia, diarrhea, 
encephalitis, corneal ulceration ,which can lead to 
significant morbidity and mortality especially in 
malnourished children.  
2. The Expanded Program of Immunization needs to 
be strengthened. Strict surveillance should be done 
and measles campaigns should be undertaken.   
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3. There is a need to improve the nutritional status of 
the children to control measles.  
4.  Every child under five years of age should get 
two doses of measles vaccine. 
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